Recro Pharma shares owned by Citadel Advisors
Quarter-by-quarter ownership of Recro Pharma (SCTL) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Recro Pharma
Tip: Access up to 7 years of quarterly data
All positions including Recro Pharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Recro Pharma by Citadel Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $56k | 159k | 0.35 |
2023-09-30 | $33k | 70k | 0.47 |
2023-06-30 | $95k | 86k | 1.10 |
2023-03-31 | $98k | 83k | 1.19 |
2022-12-31 | $44k | 29k | 1.49 |
2022-06-30 | $143k | 182k | 0.79 |
2022-03-31 | $0 | 240k | 0.00 |
2021-12-31 | $378k | 221k | 1.71 |
2021-09-30 | $629k | 306k | 2.06 |
2021-06-30 | $646k | 280k | 2.31 |
2021-03-31 | $511k | 183k | 2.79 |
2020-12-31 | $103k | 36k | 2.85 |
2020-06-30 | $65k | 14k | 4.58 |
2020-03-31 | $651k | 80k | 8.17 |
2019-12-31 | $1.8M | 99k | 18.32 |
2019-06-30 | $142k | 14k | 10.14 |
2019-03-31 | $172k | 29k | 5.89 |
2018-12-31 | $97k | 14k | 7.08 |
2018-09-30 | $229k | 32k | 7.13 |
2018-03-31 | $126k | 11k | 11.04 |